TSTickerStarGet alerts

bioAffinity Technologies Closes $4 Million Registered Direct Offering of Common Stock and Concurrent Private Placement of Warrants Priced At-The-Market

bioAffinity Technologies, Inc. (NASDAQ: BIAF, BIAFW) closed a previously announced registered direct offering of common stock (or pre-funded warrants in lieu thereof) with an institutional investor at a purchase price of $6.122 per share ($6.115 per pre-funded warrant), priced at-the-market under Nasdaq rules. The Company concurrently closed a private placement of warrants to purchase up to 980,072 shares of common stock at an exercise price of $6.122 per share, exercisable following stockholder approval and exp...

Share this story

Key takeaways

  • Closed registered direct offering of common stock (or pre-funded warrants in lieu thereof) at $6.122 per share ($6.115 per pre-funded warrant), priced at-the-market under Nasdaq rules

  • Concurrent private placement of warrants to purchase up to 980,072 shares of common stock at an exercise price of $6.122 per share

  • Pre-funded warrants have an exercise price of $0.007 per share of common stock

  • Warrants will be exercisable following stockholder approval and expire five years from the date of stockholder approval

  • Gross proceeds of approximately $4 million before deducting placement agent fees and offering expenses

  • WallachBeth Capital, LLC acted as sole placement agent for the offering

  • Offered pursuant to shelf registration statement on Form S-3 (File No. 333-275608), effective November 27, 2023

Key metrics

Gross proceeds
approximately $4 million
Common stock purchase price
$6.122
Pre-funded warrant purchase price
$6.115
Pre-funded warrant exercise price
$0.007
Private placement warrant exercise price
$6.122
Private placement warrant shares (underlying)
up to 980,072 shares
Warrant term
five years from stockholder approval
Placement agent
WallachBeth Capital, LLC (sole placement agent)

Primary source

TickerStar generated this brief from an official company, investor-relations, earnings-call, or regulatory source. Review the primary material before making an investment decision.

Open SEC filing

Follow BIAF in real time

Get material earnings, filing, IR, and earnings-call alerts by email.

Create a free alert